Prof. Bob Pinedo, MD, PhD, retired in 2008 as Professor of Medical Oncology at the VU University Medical Center. He was the founder and Chairman of the Board of the VUmc Cancer Center Amsterdam where research and patient care are closely interwoven.
He has received many international awards including the prestigious Dr Josef Steiner Cancer Research Foundation Award (1995), the NOW Spinoza Price (1997) and recently the David A. Karnofsky Memorial Award of the American Society of Clinical Oncology (2014). In 2008 Dr. Pinedo has been decorated by H.M. Queen Beatrix of the Netherlands as Knight in the Order of the Netherlands Lion. He is a member of the Royal Dutch Academy of Science and Arts and has published over 700 research articles in peer-reviewed international journals.
Cancer research and care for cancer patients is Dr. Pinedo's big passion. He is a strong believer in the use of NK cell immunotherapy for treatment of cancer patients. His scientific expertise and comprehensive network will help Glycostem to signal opportunities for its technology and products in the treatment of cancer.
Prof. Henk Verheul, MD, PhD is scientific co-director of the Cancer Center of Amsterdam and Professor of Medical Oncology. He is heading the Department of Medical Oncology in the VU University Medical Center, The Netherlands.
Henk Verheul studied Medicine at the Medical School of the Erasmus University Rotterdam and did his PhD at the Department of Medical Oncology of the VUmc. During this time, he was a research fellow from 1996 - 1998 at the Department of Surgery and Vascular Biology at the Children’s Hospital at Harvard University (Boston, USA. After he obtained his PhD (Cum Laude) on the concomitant activation of angiogenesis and coagulation in cancer, Henk Verheul started clinical training to become a medical oncologist at the University Medical Center Utrecht. In 2005 he registered as a medical oncologist and started a translational research fellowship in drug development at the Sidney Kimmel Comprehensive Cancer Center at the John Hopkins Medical Institution (Baltimore, USA) at which he currently holds a visiting Professorship position. In addition, he is an instructor for Palliative Care Management in Oncology and since 2016 chair of the Internal Medicine Division at VUmc.
Prof. Dr. Dr. Ulrike Köhl, MD, PhD is managing director at the Fraunhofer Institute for Cell Therapy and Immunology (IZI). As the newly appointed professor of immuno-oncology at Leipzig University, Prof. Köhl has also managed the Institute of Clinical Immunology at Leipzig University Hospital since December 2017. Previously, as a scientist specialising in cellular immunotherapies, she worked as a professor at the Hannover Medical School.
Prof. Köhl has extensively researched in the field of cell and gene therapy – most recently at Hannover Medical School where she managed the Institute of Cell Therapeutics from 2012 onwards. Previously, the biologist and medical expert worked in various functions at Frankfurt am Main University Hospital for many years. Moreover, her focus in experimental medicine and, in particular, the development of immune therapies also took her to the MD Anderson Cancer Center in Houston, USA.
Wim Jongen PhD, has more than 25 years of experience in R&D and Business Development in life sciences. Wim has been active in the last 7 years as investment manager in Life Sciences, is currently active as chairman of the non-executive board of directors of NTRC B.V. and has acted as chairman of the board of directors of a number of Life Science companies.